Literature DB >> 27314961

Pathological laughing and crying in amyotrophic lateral sclerosis is related to frontal cortex function.

Annemarie Hübers1, Jan Kassubek2, Georg Grön3, Martin Gorges2, Helena Aho-Oezhan2, Jürgen Keller2, Hannah Horn2, Hermann Neugebauer2, Ingo Uttner2, Dorothée Lulé2, Albert C Ludolph2.   

Abstract

The syndrome of pathological laughing and crying (PLC) is characterized by episodes of involuntary outbursts of emotional expression. Although this phenomenon has been referred to for over a century, a clear-cut clinical definition is still lacking, and underlying pathophysiological mechanisms are not well understood. In particular, it remains ill-defined which kind of stimuli-contextually appropriate or inappropriate-elicit episodes of PLC, and if the phenomenon is a result of a lack of inhibition from the frontal cortex ("top-down-theory") or due to an altered processing of sensory inputs at the brainstem level ("bottom-up-theory"). To address these questions, we studied ten amyotrophic lateral sclerosis (ALS) patients with PLC and ten controls matched for age, sex and education. Subjects were simultaneously exposed to either emotionally congruent or incongruent visual and auditory stimuli and were asked to rate pictures according to their emotional quality. Changes in physiological parameters (heart rate, galvanic skin response, activity of facial muscles) were recorded, and a standardized self-assessment lability score (CNS-LS) was determined. Patients were influenced in their rating behaviour in a negative direction by mood-incongruent music. Compared to controls, they were influenced by negative stimuli, i.e. they rated neutral pictures more negatively when listening to sad music. Patients rated significantly higher on the CNS-LS. In patients, changes of electromyographic activity of mimic muscles during different emotion-eliciting conditions were explained by frontal cortex dysfunction. We conclude that PLC is associated with altered emotional suggestibility and that it is preferentially elicited by mood-incongruent stimuli. In addition, physiological reactions as well as behavioural changes suggest that this phenomenon is primarily an expression of reduced inhibitory activity of the frontal cortex, since frontal dysfunction could explain changes in physiological parameters in the patient group. We consider these findings being important for the clinical interpretation of emotional reactions of ALS patients.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Emotion induction; Frontal cortex; Pathological laughing and crying; Pseudobulbar affect

Mesh:

Year:  2016        PMID: 27314961     DOI: 10.1007/s00415-016-8201-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Measuring pseudobulbar affect in ALS.

Authors:  Richard A Smith; James E Berg; Laura E Pope; Ronald A Thisted
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2004-09

3.  The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population.

Authors:  Dorothée Lulé; Christian Burkhardt; Susanne Abdulla; Sarah Böhm; Katja Kollewe; Ingo Uttner; Sharon Abrahams; Thomas H Bak; Susanne Petri; Markus Weber; Albert C Ludolph
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-10-08       Impact factor: 4.092

4.  Pathological laughing and weeping in patients with progressive balbar palsy.

Authors:  K Poeck
Journal:  Ger Med Mon       Date:  1969-08

Review 5.  Pathological laughing and crying.

Authors:  F L Dark; J J McGrath; M A Ron
Journal:  Aust N Z J Psychiatry       Date:  1996-08       Impact factor: 5.744

6.  Pathological laughter and crying: a link to the cerebellum.

Authors:  J Parvizi; S W Anderson; C O Martin; H Damasio; A R Damasio
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

Review 7.  Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments.

Authors:  Ariel Miller; Hillel Pratt; Randolph B Schiffer
Journal:  Expert Rev Neurother       Date:  2011-05-03       Impact factor: 4.618

Review 8.  Neuroanatomy of pathological laughing and crying: a report of the American Neuropsychiatric Association Committee on Research.

Authors:  Josef Parvizi; Kerry L Coburn; Samuel D Shillcutt; C Edward Coffey; Edward C Lauterbach; Mario F Mendez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

9.  Neuroimaging of serotonin transporters in post-stroke pathological crying.

Authors:  Toshiya Murai; Henryk Barthel; Jörg Berrouschot; Dietlind Sorger; D Yves von Cramon; Ulrich Müller
Journal:  Psychiatry Res       Date:  2003-07-30       Impact factor: 3.222

10.  Screening for cognition and behaviour changes in ALS.

Authors:  Sharon Abrahams; Judith Newton; Elaine Niven; Jennifer Foley; Thomas H Bak
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-06-19       Impact factor: 4.092

View more
  1 in total

1.  Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort.

Authors:  Francesca Trojsi; Mattia Siciliano; Cinzia Femiano; Gabriella Santangelo; Christian Lunetta; Andrea Calvo; Cristina Moglia; Kalliopi Marinou; Nicola Ticozzi; Gianluca Drago Ferrante; Carlo Scialò; Gianni Sorarù; Amelia Conte; Yuri M Falzone; Rosanna Tortelli; Massimo Russo; Valeria Ada Sansone; Adriano Chiò; Gabriele Mora; Barbara Poletti; Paolo Volanti; Claudia Caponnetto; Giorgia Querin; Mario Sabatelli; Nilo Riva; Giancarlo Logroscino; Sonia Messina; Antonio Fasano; Maria Rosaria Monsurrò; Gioacchino Tedeschi; Jessica Mandrioli
Journal:  J Neurol       Date:  2017-09-15       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.